MOQ | 1000 Box |
Port | Kuala Lumpur |
Packaging | Box |
Lead Time | 4 |
CARESTART COVID-19 ANTIGEN TEST RCHM-02071
The CareStart™ COVID-19 Antigen test is a lateral flow
immunochromatographic assay intended for the qualitative
detection of the nucleocapsid protein antigen from SARS-CoV-2 in
nasopharyngeal swab specimens directly collected, or collected in
BD universal transport media, from individuals suspected of
COVID-19 by their healthcare provider within five days of symptom
onset. Testing is limited to laboratories certified under the
Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42
U.S.C. §263a, that meet the requirements to perform moderate,
high or waived complexity tests. This test is authorized for use
at the Point of Care (POC), i.e., in patient care settings
operating under a CLIA Certificate of Waiver, Certificate of
Compliance, or Certificate of Accreditation.